Pharmaceutical - GlaxoSmithKline


Current filters:


Popular Filters

176 to 200 of 421 results

Case study draws attention to innovator brand preferences in Kenya


Some of the stronger performing brands in Kenya’s pharmaceutical market have been highlighted in a…

Antibiotics and Infectious diseasesCardio-vascularDiabetesGlaxoSmithKlineMarkets & MarketingPharmaceuticalRest of the World

New data support GSK plan to file for approval of malaria vaccine in 2014

New data support GSK plan to file for approval of malaria vaccine in 2014


Results from a large-scale Phase III trial, presented today at the Multilateral Initiative on Malaria…

GlaxoSmithKlinePharmaceuticalRegulationResearchRTS,STropical diseasesVaccines

Isis earns milestone payments from GlaxoSmithKline

Isis earns milestone payments from GlaxoSmithKline


US biotech firm Isis Pharmaceuticals says that UK pharma giant GlaxoSmithKline has added a development…

BiotechnologyFinancialGlaxoSmithKlineIsis PharmaceuticalsLicensingPharmaceuticalRare diseases

GSK and Genmab file for Arzerra variation in Europe


GlaxoSmithKline ) and partner Genmab have submitted a variation to the Marketing Authorization to the…


GSK stock will remain strong despite slowing emerging markets, say analysts

GSK stock will remain strong despite slowing emerging markets, say analysts


Following concerns from Eli Lilly about the slowdown of emerging markets and devaluation of the Japanese…


GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen


GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

UK’s NICE issues draft guidance on suite of ovarian cancer drugs


Drugs watchdog the National Institute for Health and Care Excellence (NICE) is currently considering…

Europegemcitabine HclGlaxoSmithKlineJohnson & JohnsonLillyOncologyPharmaceuticalPricingRegulationtrabectedin

US FDA warns of hepatitis B reactivation risk with Arzerra and Rituxan

US FDA warns of hepatitis B reactivation risk with Arzerra and Rituxan


The US Food and Drug Administration has approved changes to the prescribing information of the immune-suppressing…

Anti-Arthritics/RheumaticsArzerraBiogen IdecGlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationRituxanRoche

Prosensa stock goes into free fall as drisapersen fails in Ph III study


UK pharma giant GlaxoSmithKline and Netherlands-based partner Prosensa announced on Friday that GSK's…

drisaperseneteplirsenGlaxoSmithKlinePharmaceuticalProsensaRare diseasesResearchSarepta Therapeutics

Positive CHMP recommendation for Relvar Ellipta


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) announced that the…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryTheravance

US HHS replenishes nation's supply of anthrax antitoxin


The USA’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts…

Cangene CorpElusys TherapeuticsEmergent ProductsGlaxoSmithKlineHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPharmAthene

US NIH trials flu vaccines from Sanofi and Novartis

US NIH trials flu vaccines from Sanofi and Novartis


The US National Institutes of Health has begun testing an H7N9 avian influenza vaccine candidate in humans.

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalSanofi PasteurVaccines

GlaxoSmithKline returns rights to vercirnon


US drug developer ChemoCentryx (Nasdaq: CCXI) says that partner GlaxoSmithKline (LSE: GSK), the UK’s…

ChemoCentryxGastro-intestinalsGlaxoSmithKlineLicensingNorth AmericaPharmaceuticalvercirnon

GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs


UK pharma giant GlaxoSmithKline (LSE: GSK) and Community Care of North Carolina (CCNC) today announced…

FinancialGlaxoSmithKlineHealthcareNorth AmericaPharmaceutical

Positive developments for GSK's Tafinlar/Mekinist and Arzerra


UK pharma giant GlaxoSmithKline (LSE: GSK) has announced positive news relating to three of its drugs,…

ArzerraBiotechnologyGenmabGlaxoSmithKlineMekinistNorth AmericaOncologyPharmaceuticalRegulationTafinlar

AHF sues GSK for failing to provide discounts on HIV/AIDS drugs


The USA-based AIDS Healthcare Foundation (AHF) said yesterday (September 10) that it has filed a law…

Anti-viralsGlaxoSmithKlineLegalNorth AmericaPharmaceuticalPricing

Aspen Pharma reports rise in profits from new product launches


South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

FDA advisory panel gives thumbs up for Anoro Ellipta approval


There was a bit of good news for UK pharma giant GlaxoSmithKline yesterday (LSE: GSK) and partner USA-based…

Anoro ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

Generic risk to GSK's Advair prompts buy recommendation from analysts


Pharmaceutical analysts are urging investors to buy shares of UK pharma major GlaxoSmithKline (LSE: GSK)…

AdvairAstraZenecaBoehringer IngelheimEuropeFinancialGlaxoSmithKlinePharmaceuticalRespiratory and PulmonarySandozSpirivaSymbicort

GSK's Anoro Ellipta shows efficacy in COPD, say FDA briefing papers


UK drug major GlaxoSmithKline's (LSE: GSK) Anoro Ellipta (vilanterol/umeclidinium) to treat chronic obstructive…

Anoro ElliptaBreo ElliptaGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTheravance

GSK sells soft drinks Lucozade and Ribena for £1.35 billion to focus on pharma and vaccines


UK pharma major GlaxoSmithKline (LSE: GSK) has sold its nutritional drinks brands Lucozade and Ribena…


GlaxoSmithKline could be considering quitting China, says BBC editor


For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

176 to 200 of 421 results

Back to top